Balancing risk versus benefit: The elderly patient's perspective on warfarin therapy

Pharmacy Practice

Volumn 7, Issue 2, 2009, Pages 113-123

  Bajorek, Beata V ^a   Ogle, Susan J ^b   Duguid, Margaret J ^b   Shenfield, Gillian M ^b   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Aged; Attitude to health; Australia; Qualitative research; Warfarin

Indexed keywords

WARFARIN;

AGED; ARTICLE; ATTITUDE TO HEALTH; CAREGIVER; CLINICAL ARTICLE; DRUG INFORMATION; ELDERLY CARE; GERIATRICS; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; QUALITATIVE RESEARCH; RISK BENEFIT ANALYSIS; SEMI STRUCTURED INTERVIEW; STROKE; TREATMENT DURATION;

EID: 70349218889     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552009000200008     Document Type: Article

References (29)

1. Enis J. Stroke prevention in patients with non-valvular atrial fibrillation: a current community perspective. J Clin Neuroscience. 1997;4:320-325.
2. Ang S, Peterson G, Friesen W, Vial J. Review of antithrombotic drug usage in atrial fibrillation. J Clin Pharm Ther. 1998;23:97-106.
3. Stewart F, Singh Y, Persson S, Gamble G, Braatvedt G. Atrial fibrillation: prevalence and management in an acute general medical unit. Aust NZ J Mad. 1999;29:51-58.
4. Elliott R, Woodward M, Obome C. Appropriateness of antithrombotic prescribing for elderly inpatients with atrial fibrillation. Pharm J. 1999;263:R10.
5. Jackson S, Peterson G, Vial J, Daud R, Ang S. Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice. Intern Med J. 2001;31:329-336.
6. Bajorek B, Krass I, Ogle S, Duguid M, Shenfield G. The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australas J Ageing. 2002;21:36-41.
7. Chang H, Bell J, Devoo D, Kirk J, Wasson J. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med. 1990;150:81-84.
8. Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med. 1991;151:1950-1953.
9. McCrory D, Matchar D, Samsa G, Sanders L, Pritchett E. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155(3):277-281.
10. Munschauer F, Priore R, Hens M, Castilone A. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. Stroke. 1997;28:72-76.
11. Howitt A, Armstrong D. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillafion. BMJ. 1999;318:1324-1327.
12. Gottlieb L, Salem-Schatz S. Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med. 1994;154:1945-1953.
13. Morgan D, Kreuger R. When to use focus groups and why? In: Morgan D, editor. Successful focus groups. London: Sage; 1993.
14. White Y, Grenyer B. The biopsychosocial impact of end-stage renal disease: the experience of dialysis patients and their partners. J Adv Nurs.1999;30:1312-1320.
15. Husseri E. Ideas: general introduction to pure phenomenology. Evanston, Illinois: Northwestern University Press; 1931.
16. Moustakas C. Phenomenological research methods. Thousand Oaks, California: Sage; 1994.
17. Kidd P, Parshall M. Getting the focus and the group: enhancing analytical rigor in focus group research. Qual Health Res. 2000;10:293-308.
18. McCrory D, Matchar D, Samsa G, Sanders L, Pritchett E. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med. 1995;155:277-281
19. Lip G, Zarifis J, Watson R, Beavers D. Physician variation in the management of patients with atrial fibrillation. Heart. 1996;75:200-205.
20. Peterson G, Boom K, Jackson S, Vial J. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention. Intern Med J. 2002;32:15-23.
21. Amsten J, Gelfand J, Singer D. Determinants of compliance with anticoagulation: a case-control study. Am J Med. 1997;103:11-17.
22. Man-Son-Hing M, Laupacis A, O'Connor A, Wells G. Warfarin for atrial fibrilation: the patient's perspectives. Arch Intern Med. 1996;156:1841-1848.
23. Peyrot M, McMurry J, Kruger D. A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence. J Health Soc Beh. 1999;40(2):141-158.
24. Barber N, Parsons J, Clifford S, Darracott R, Home R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care. 2004; 13:172-175.
25. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough? BMJ. 1999;318:318-322.
26. Dickinson D, Raynor D, Kennedy J, Bonaccorso S, Sturchio J. What information do patients need about medicines? BMJ. 2003;327:861.
27. Kyngas H. Patient education: perspective of adolescents with a chronic disease. J Clin Nurs. 2003; 12(5):744-751.
28. Berry D, Michas I, Gillie T, Forster M. What do patients want to know about their medicines and what do doctors want to tell them? A comparative study. Psychol Health. 1997;12:467-480.
29. Britten N, Stevenson F, Barry C, Barber N, Bradley C. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000;320:484-488.